71P Real-world treatment patterns and clinical outcomes for patients who received sintilimab (Sint) in first-line treatment of advanced non-small cell lung cancer (NSCLC) in China: A multicenter retrospective observational study. (December 2022) - Yu, Y.; Shang, L.; Xie, Q.; Ying, K.; Jin, B.; Zhang, L.; Liu, L.; Li, J.; Ding, W.